Advertisement

CQ43. What Is the Benefit of RAI Therapy for Local Recurrence, Lymph Node Metastasis and Distant Metastasis of Differentiated Thyroid Carcinoma?

  • Seigo Kinuya
  • Naoyuki Shigematsu
  • Yasushi Noguchi
  • Tatsuya Higashi
Chapter

Abstract

The effect and significance of RAI therapy for remnant tumors vary greatly according to the location of the tumor.

Keywords

Local Recurrence Distant Metastasis Bone Metastasis Brain Metastasis Thyroid Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338:297–306 (NR)PubMedCrossRefGoogle Scholar
  2. 2.
    Yoshida A (2002) (Text in Japanese) Rinsho Geka 57:48–54 (SR<RS>)Google Scholar
  3. 3.
    Shibuya H, Sugino K, Nagahama M et al (2007) (Text in Japanese) Rinsho Hoshasen 52:847–854 (RS)Google Scholar
  4. 4.
    Dottorini ME, Vignati A, Mazzucchelli L et al (1997) Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med 38:669–675 (RS)PubMedGoogle Scholar
  5. 5.
    Schlumberger M, Challeton C, De Vathaire F et al (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37:598–605 (RS)PubMedGoogle Scholar
  6. 6.
    Durante C, Haddy N, Baudin E et al (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91:2892–2899 (RS)PubMedCrossRefGoogle Scholar
  7. 7.
    Bernier MO, Leenhardt L, Hoang C et al (2001) Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568–1573 (RS)PubMedCrossRefGoogle Scholar
  8. 8.
    Misaki T, Iwata M, Kasagi K et al (2000) Brain metastasis from differentiated thyroid cancer in patients treated with radioiodine for bone and lung lesions. Ann Nucl Med 14:111–114 (RS)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Seigo Kinuya
    • 1
  • Naoyuki Shigematsu
    • 2
  • Yasushi Noguchi
    • 3
  • Tatsuya Higashi
    • 4
  1. 1.Department of Nuclear Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health ScienceKanazawa UniversityKanazawaJapan
  2. 2.Department of RadiologyKeio University School of MedicineTokyoJapan
  3. 3.Department of RadiologyNoguchi Thyroid Clinic and Hospital FoundationBeppuJapan
  4. 4.Shiga Medical Center Research InstituteOtsu-shiJapan

Personalised recommendations